4/2
12:04 pm
kala
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Low
Report
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
4/1
10:15 am
kala
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Low
Report
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
3/29
08:00 am
kala
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2/26
08:00 am
kala
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
Low
Report
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
2/6
08:00 am
kala
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
Low
Report
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference